Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $47,936 - $86,707
-369 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$109.18 - $185.98 $39,959 - $68,068
366 Added 12200.0%
369 $48,000
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $81,188 - $209,777
-1,235 Reduced 99.76%
3 $0
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $8,368 - $14,606
154 Added 14.21%
1,238 $87,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $32,162 - $86,720
1,084 New
1,084 $69,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.